Obesity and Diabetes;Obezita a Diabetes

Vnitrni Lekarstvi

Volumn 49, Issue 12, 2003, Pages 956-959

  Olšovský, Jindřich ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Diabetes mellitus; Metabolic syndrome; Obesity

Indexed keywords

ARTICLE; BODY MASS; HUMAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; TREATMENT PLANNING;

EID: 1642430799     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bobbioni-Harrsch, E. et al.: Leptin plasma levels as a marker of sparing energy metabolismin obese women. Int. J. Obesity, 23, 1999, 470-475
2. Bray, G. A. et al.: Sibutramin produces dose related Weight loss. Obesity Research 7, 1999, 189-198
3. Colemann, R. A. et al.: Nutritional regulation of leptin in humans. Diabetiologia 42, 1999, 639-646
4. Considine, R. V.: Leptin and obesity in humans. Eating and Weight Disorders 2, 1997, 61-66
5. Erikson, J. et al.: Prevention of type 2 diabetes in subject with impaired glucose tolerance the DPOS Study in Finland. Diabetologia 42, 1999, 793-801
6. Hainer, V. et al.: Doporučený standardní postup při léčbě obezity v dospělosti. DMEV 1, 1998, 4, 191-196
7. Hollander, P. A. et al.: Role of orlistat in the treatment of Obese Patients with type 2 diabetes. Diabetes care 21, 8, 1998, 1288-1294
8. Kolektiv autorů Roche: Xenical. Monografie, Praha 1999
9. Lean, M. E. J.: Sibutramine - a review of clinical efficacy. Int. J. Obesity 21, 1997, 30-36
10. Perušičová, J. et al.: Diabetes mellitus 2. typu. Galén 1996
11. Svačina, Š.: Obezita a diabetes. Maxdorf 2000, 216 s.
12. Svačina, Š.: Syndrom inzulinové rezistence. Triton 2003, 89-91